Both SRXN1 and KRT6A were significantly upregulated in NSCLC tissues relative to non-tumor tissues (5.07 ± 3.65 fold and 6.80 ± 4.53 fold, respectively; both P < 0.001, Figures 4A, B). This evidence concerns the gene SRXN1 and neoplasm.